Agoracom

Hello everyone-

I've been concerned that we have no news from Cypress regarding the Phase lll Indaflex trial. So, I wrote their investor relations person and am awaiting an answer perhaps tomorrow (Monday). In spite of the fact that Cypress just completed their purchase of Proprius, they have paid as much as five times the entire market cap of ALRX for this one product and I, for one, would think they'd get the trial moving quickly. There is nothing mentioned on their website other than the purchase of Proprius.

I'll let you know what, if anything, I hear. In the meantime, any comments would be appreciated.

Cheers,

Mavenwood